Royer H D, Freyaldenhoven M P, Napierski I, Spitkovsky D D, Bauknecht T, Dathan N
Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, FRG.
Nucleic Acids Res. 1991 May 11;19(9):2363-71. doi: 10.1093/nar/19.9.2363.
The enhancer of human papillomavirus type 18 consists of two functionally redundant domains, one is partially conserved between HPV18 and HPV16, both mediate strong transcriptional enhancement. In contrast, short fragments of the enhancer mediate low transcriptional enhancement, suggesting that there is functional cooperation between HPV enhancer binding factors. Previously interactions of the enhancer with NF-1, AP1 and steroid receptors were shown by EMSA. Here we show by binding site blotting, that four novel sequence specific proteins p110, p92, p42 and p40 bind to the enhancer. Nuclear proteins p110 and p92 bind at repeated sites in the enhancer, proteins p42 and p40 only at one site. Recognition sequences for p110 and p92 were identified in a TTGCTTGCATAA sequence motif and consist of an overlapping p110 and p92 recognition site. The specific interaction of p110 with G residues of this 12 nucleotide long sequence was demonstrated by a mutant recognition site. Single recognition sites for p42 and p40 were localized in the enhancer by the use of overlapping oligonucleotides. In addition, electrophoretic mobility shift analysis identified Oct-1 and AP2 interactions with the enhancer. The AP2 binding site was mapped to a AGGCACATATT motif. The p92 protein binds to enhancer oligonucleotides, containing at least one copy of Oct-1 like recognition sequences, these oligonucleotides also bind synthetic Oct-1 protein. During serum starvation or at high saturation density, p92 moves from the nucleus into the cytoplasm. Immunoblots of cytoplasmic extracts with anti-Oct-1 antisera showed, that p92 is a novel octamer binding factor, which is not immunologically related to the Oct-1 protein. The intracellular p92 distribution is regulated at the G0/G1 boundary of the cell cycle, by nucleo-cytoplasmic translocation.
人乳头瘤病毒18型增强子由两个功能冗余结构域组成,其中一个在HPV18和HPV16之间部分保守,二者均介导强烈的转录增强。相比之下,增强子的短片段介导低水平的转录增强,提示HPV增强子结合因子之间存在功能协同作用。此前通过电泳迁移率变动分析(EMSA)显示增强子与NF-1、AP1及类固醇受体之间存在相互作用。在此我们通过结合位点印迹法表明,四种新的序列特异性蛋白p110、p92、p42和p40与该增强子结合。核蛋白p110和p92在增强子的重复位点结合,蛋白p42和p40仅在一个位点结合。在TTGCTTGCATAA序列基序中鉴定出p110和p92的识别序列,其由一个重叠的p110和p92识别位点组成。通过突变识别位点证明了p110与这个12个核苷酸长序列的G残基之间的特异性相互作用。通过使用重叠寡核苷酸将p42和p40的单个识别位点定位在增强子中。此外,电泳迁移率变动分析确定了Oct-1和AP2与增强子的相互作用。AP2结合位点定位到AGGCACATATT基序。p92蛋白与含有至少一个Oct-1样识别序列拷贝的增强子寡核苷酸结合,这些寡核苷酸也结合合成的Oct-1蛋白。在血清饥饿或高饱和密度时,p92从细胞核转移到细胞质中。用抗Oct-1抗血清对细胞质提取物进行免疫印迹显示,p92是一种新的八聚体结合因子,与Oct-1蛋白无免疫相关性。细胞内p92的分布在细胞周期的G0/G1边界通过核质转运进行调节。